Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inflammation, oxidative stress, and working memory during GHB detoxification
NL-OMON51379Not yet recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of sodium oxybate in gamma-hydroxybutyrate use disorder (GHBUD), sponsored by Radboud University Medical Center. Primary endpoints: Interleukin-6, Interleukin-8 and 7 more. Planned start Oct 2022; status: not yet recruiting.
02
Drugs
sodium oxybate
03
Conditions
gamma-hydroxybutyrate use disorder (GHBUD)
Beyond the preview
Go deeper on NL-OMON51379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51379.